Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 12 | $1,463,487 |
| Sells | 4 | $13,994 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 61,134 | 0.6928 | 42,354 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 5,041 | 0.6928 | 3,492 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 93,091 | 0.6924 | 64,456 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 7,676 | 0.6924 | 5,315 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 4,434 | 0.6828 | 3,028 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 366 | 0.6828 | 250 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 207,676 | 0.6805 | 141,324 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 17,124 | 0.6805 | 11,653 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 4,342 | 0.665 | 2,887 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 358 | 0.665 | 238 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 1,740,581 | 0.6308 | 1,097,958 | I |
| 17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 143,519 | 0.6308 | 90,532 | I |
| 14 Aug 2023 16:06 | NLTX | Neoleukin Therapeutics Inc | SMITH SEAN MICHAEL | Interim CFO, Prin Acct Off | 11 Aug 2023 | Sale | 1,323 | 0.6184 | 818 | D |
| 04 Apr 2023 20:51 | NLTX | Neoleukin Therapeutics Inc | PATEL PRITI | Former Chief Medical Officer | 03 Apr 2023 | Sale | 3,769 | 0.6919 | 2,608 | D |
| 03 Feb 2023 16:33 | NLTX | Neoleukin Therapeutics Inc | SMITH SEAN MICHAEL | Principal Accounting Officer | 02 Feb 2023 | Sale | 3,316 | 0.5972 | 1,980 | D |
| 03 Feb 2023 16:32 | NLTX | Neoleukin Therapeutics Inc | PATEL PRITI | Chief Medical Officer | 02 Feb 2023 | Sale | 14,380 | 0.5972 | 8,588 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)